CLINICAL ROLE -
Therapies for CINV Prevention and Management
Watch
The Biology of CINV
The Importance of Treating CINV
Depression in Multiple Sclerosis Linked to Brain Inflammation
Researchers target causes of severe depression in MS patients.
Read More
FDA Approves Novel Type 2 Diabetes Treatment
Adlyxin maintains normal A1c levels in patients with type 2 diabetes.
New Type 2 Diabetes Drug Approved by FDA
Adlyxin is a once-daily injection that improves glycemic control in type 2 diabetes.
California City Recommends MSM Receive Meningococcal Vaccine
A recent outbreak of invasive meningococcal disease has been seen mostly among men who have sex with men.
Trending News Today: Treatment for Alzheimer's Disease Disappoints in Early Trial
Top news of the day from across the health care landscape.
Trending News Today: Anthem Fights Lawsuit Blocking Merger with Cigna
Top news of the day from across the healthcare landscape.
Genetic Signature Presents New Ovarian Cancer Drug Target
Analysis of HOX gene able to predict survival in ovarian cancer.
TRPV6 Imaging Could Lead to Novel Cancer Treatments
Altered TRPV6 expression is linked to cancer and other diseases.
Weight Loss Could Lead to Decreased Expression of Cancer-Promoting Proteins
Participants who lost weight showed decreased expression of proteins that promote tumor-related angiogenesis.
FDA Approves New GLP-1 Receptor Agonist Adlyxin for Diabetes
The FDA has just approved Sanofi's lixisenatide (Adlyxin), a new glucagon-like peptide-1 (GLP-1) receptor agonist to improve glycemic control, in conjunction with diet and exercise, in adults with type 2 diabetes.
Former Pharmacy Owner Sentenced to Prison for Stealing from Charity
The former owner of a pharmacy in Lexington, Kentucky, has been sentenced to more than 6 years in prison for stealing $1.1 million from a charity called Chronic Disease Fund.
Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel Oncolytic Virus Technology
ACPE Installs New Board Members for 2016-2022 Term of Service
FDA Panel Backs Diabetes Diagnostic Device
An FDA advisory panel recently gave the green light for a hemoglobin A1C test to diagnose diabetes in certain care settings.
The Ketogenic Diet for Seizure Control
With so much emphasis on reduced-fat" or fat-free" foods, it could come as a surprise that studies have been conducted on the usefulness of the ketogenic diet for seizure control.
Grindr Pilots HIV Home Testing Promotion
Could the world's largest gay social network be an effective vehicle to offer free home testing to men at high risk for HIV?
OTC Statins Could Reduce Cardiovascular Events, Deaths
Approximately 7.3 million patients who are eligible would start over-the-counter statin treatments.
Florida Residents Charged in the Largest Medicare Fraud Scheme to Date
Conspirators filed over $1 billion in false Medicare and Medicaid claims.
HIV-Transmission Drops Among Heterosexuals on Antiretroviral Therapy
There was a 93% decrease in transmission among HIV-positive individuals taking ART.
Time-to-Fill: A Standardization Dilemma in Specialty Pharmacy
Standardizing measurements across the lifecycle of a prescription will help specialty pharmacies demonstrate success.
Most Insurers Do Not Use Value Frameworks in Prescription Drug Coverage Decisions
Analysis finds health plans need to examine total treatment costs instead of just drug costs.
Vemurafenib Shows Anti Tumor Activity in Thyroid Cancer
Vemurafenib is a multi-targeted kinase inhibitor originally approved to treat melanoma patients with a BRAF mutation.
Phase 3 Trial for Novel HIV Drug Begins Enrollment
New class of HIV medications called viral-entry inhibitors protect healthy cells from viral infection.
No Link Found Between Diabetes Treatment and Mortality
Researchers were unable to find a strong link between diabetes drugs and cardiovascular mortality.
Disposable Pouch Could Lead to Improved Medication Disposal
Deterra dissolves unused medications and can then be disposed of in the garbage.
Trending News Today: Concerns Raised Over Clinical Trials Website
Once-Daily Hepatitis C Treatment Approved by FDA
Veikira XR is a once-daily medication that treats hepatitis C genotype 1.